0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Newborn Metabolic Screening Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-2P13238
Home | Market Reports | Health| Nursing
Global Newborn Metabolic Screening Market Research Report 2023
BUY CHAPTERS

Global Newborn Metabolic Screening Market Research Report 2025

Code: QYRE-Auto-2P13238
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Newborn Metabolic Screening Market Size

The global market for Newborn Metabolic Screening was valued at US$ 814 million in the year 2024 and is projected to reach a revised size of US$ 1341 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Newborn Metabolic Screening Market

Newborn Metabolic Screening Market

Newborn metabolic screening, also known as newborn screening or heel-stick testing, is a public health program aimed at identifying certain metabolic, genetic, and congenital disorders in newborns shortly after birth. The screening involves collecting a small blood sample, typically obtained by pricking the newborn"s heel, and testing it for the presence of specific markers associated with these disorders. Early detection allows for prompt intervention and treatment, often preventing or minimizing the development of serious health issues.
Continuous expansion of newborn screening panels to include additional metabolic, genetic, and congenital disorders. Advances in genetic testing technologies may contribute to the identification of new conditions.
This report aims to provide a comprehensive presentation of the global market for Newborn Metabolic Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Metabolic Screening.
The Newborn Metabolic Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newborn Metabolic Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Metabolic Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Newborn Metabolic Screening Market Report

Report Metric Details
Report Name Newborn Metabolic Screening Market
Accounted market size in year US$ 814 million
Forecasted market size in 2031 US$ 1341 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Specialty Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company PerkinElmer, Bio-Rad Laboratories, Trivitron Healthcare Private Limited, BioMedomics, Inc., Luminex Corporation, MP BIOMEDICALS, Synergy Medical Systems LLP, Agilent Technologies, Inc, Thermo Fisher Scientific, Inc, Zivak Technologies, Covidien Plc, AB Sciex LLC, Waters Corp., Masimo Corp., Natus Medical Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Newborn Metabolic Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Newborn Metabolic Screening Market growing?

Ans: The Newborn Metabolic Screening Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Newborn Metabolic Screening Market size in 2031?

Ans: The Newborn Metabolic Screening Market size in 2031 will be US$ 1341 million.

Who are the main players in the Newborn Metabolic Screening Market report?

Ans: The main players in the Newborn Metabolic Screening Market are PerkinElmer, Bio-Rad Laboratories, Trivitron Healthcare Private Limited, BioMedomics, Inc., Luminex Corporation, MP BIOMEDICALS, Synergy Medical Systems LLP, Agilent Technologies, Inc, Thermo Fisher Scientific, Inc, Zivak Technologies, Covidien Plc, AB Sciex LLC, Waters Corp., Masimo Corp., Natus Medical Inc.

What are the Application segmentation covered in the Newborn Metabolic Screening Market report?

Ans: The Applications covered in the Newborn Metabolic Screening Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Newborn Metabolic Screening Market report?

Ans: The Types covered in the Newborn Metabolic Screening Market report are Blood Test, Urine Test

Recommended Reports

Newborn Monitoring Devices

Neonatal Medical Devices

Neonatal & Metabolic Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Metabolic Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Test
1.2.3 Urine Test
1.3 Market by Application
1.3.1 Global Newborn Metabolic Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Metabolic Screening Market Perspective (2020-2031)
2.2 Global Newborn Metabolic Screening Growth Trends by Region
2.2.1 Global Newborn Metabolic Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Newborn Metabolic Screening Historic Market Size by Region (2020-2025)
2.2.3 Newborn Metabolic Screening Forecasted Market Size by Region (2026-2031)
2.3 Newborn Metabolic Screening Market Dynamics
2.3.1 Newborn Metabolic Screening Industry Trends
2.3.2 Newborn Metabolic Screening Market Drivers
2.3.3 Newborn Metabolic Screening Market Challenges
2.3.4 Newborn Metabolic Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Metabolic Screening Players by Revenue
3.1.1 Global Top Newborn Metabolic Screening Players by Revenue (2020-2025)
3.1.2 Global Newborn Metabolic Screening Revenue Market Share by Players (2020-2025)
3.2 Global Newborn Metabolic Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Newborn Metabolic Screening Revenue
3.4 Global Newborn Metabolic Screening Market Concentration Ratio
3.4.1 Global Newborn Metabolic Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Metabolic Screening Revenue in 2024
3.5 Global Key Players of Newborn Metabolic Screening Head office and Area Served
3.6 Global Key Players of Newborn Metabolic Screening, Product and Application
3.7 Global Key Players of Newborn Metabolic Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Metabolic Screening Breakdown Data by Type
4.1 Global Newborn Metabolic Screening Historic Market Size by Type (2020-2025)
4.2 Global Newborn Metabolic Screening Forecasted Market Size by Type (2026-2031)
5 Newborn Metabolic Screening Breakdown Data by Application
5.1 Global Newborn Metabolic Screening Historic Market Size by Application (2020-2025)
5.2 Global Newborn Metabolic Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Newborn Metabolic Screening Market Size (2020-2031)
6.2 North America Newborn Metabolic Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Newborn Metabolic Screening Market Size by Country (2020-2025)
6.4 North America Newborn Metabolic Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Metabolic Screening Market Size (2020-2031)
7.2 Europe Newborn Metabolic Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Newborn Metabolic Screening Market Size by Country (2020-2025)
7.4 Europe Newborn Metabolic Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Metabolic Screening Market Size (2020-2031)
8.2 Asia-Pacific Newborn Metabolic Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Newborn Metabolic Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Newborn Metabolic Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Metabolic Screening Market Size (2020-2031)
9.2 Latin America Newborn Metabolic Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Newborn Metabolic Screening Market Size by Country (2020-2025)
9.4 Latin America Newborn Metabolic Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Metabolic Screening Market Size (2020-2031)
10.2 Middle East & Africa Newborn Metabolic Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Newborn Metabolic Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Newborn Metabolic Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Details
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Newborn Metabolic Screening Introduction
11.1.4 PerkinElmer Revenue in Newborn Metabolic Screening Business (2020-2025)
11.1.5 PerkinElmer Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Newborn Metabolic Screening Introduction
11.2.4 Bio-Rad Laboratories Revenue in Newborn Metabolic Screening Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Trivitron Healthcare Private Limited
11.3.1 Trivitron Healthcare Private Limited Company Details
11.3.2 Trivitron Healthcare Private Limited Business Overview
11.3.3 Trivitron Healthcare Private Limited Newborn Metabolic Screening Introduction
11.3.4 Trivitron Healthcare Private Limited Revenue in Newborn Metabolic Screening Business (2020-2025)
11.3.5 Trivitron Healthcare Private Limited Recent Development
11.4 BioMedomics, Inc.
11.4.1 BioMedomics, Inc. Company Details
11.4.2 BioMedomics, Inc. Business Overview
11.4.3 BioMedomics, Inc. Newborn Metabolic Screening Introduction
11.4.4 BioMedomics, Inc. Revenue in Newborn Metabolic Screening Business (2020-2025)
11.4.5 BioMedomics, Inc. Recent Development
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Details
11.5.2 Luminex Corporation Business Overview
11.5.3 Luminex Corporation Newborn Metabolic Screening Introduction
11.5.4 Luminex Corporation Revenue in Newborn Metabolic Screening Business (2020-2025)
11.5.5 Luminex Corporation Recent Development
11.6 MP BIOMEDICALS
11.6.1 MP BIOMEDICALS Company Details
11.6.2 MP BIOMEDICALS Business Overview
11.6.3 MP BIOMEDICALS Newborn Metabolic Screening Introduction
11.6.4 MP BIOMEDICALS Revenue in Newborn Metabolic Screening Business (2020-2025)
11.6.5 MP BIOMEDICALS Recent Development
11.7 Synergy Medical Systems LLP
11.7.1 Synergy Medical Systems LLP Company Details
11.7.2 Synergy Medical Systems LLP Business Overview
11.7.3 Synergy Medical Systems LLP Newborn Metabolic Screening Introduction
11.7.4 Synergy Medical Systems LLP Revenue in Newborn Metabolic Screening Business (2020-2025)
11.7.5 Synergy Medical Systems LLP Recent Development
11.8 Agilent Technologies, Inc
11.8.1 Agilent Technologies, Inc Company Details
11.8.2 Agilent Technologies, Inc Business Overview
11.8.3 Agilent Technologies, Inc Newborn Metabolic Screening Introduction
11.8.4 Agilent Technologies, Inc Revenue in Newborn Metabolic Screening Business (2020-2025)
11.8.5 Agilent Technologies, Inc Recent Development
11.9 Thermo Fisher Scientific, Inc
11.9.1 Thermo Fisher Scientific, Inc Company Details
11.9.2 Thermo Fisher Scientific, Inc Business Overview
11.9.3 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Introduction
11.9.4 Thermo Fisher Scientific, Inc Revenue in Newborn Metabolic Screening Business (2020-2025)
11.9.5 Thermo Fisher Scientific, Inc Recent Development
11.10 Zivak Technologies
11.10.1 Zivak Technologies Company Details
11.10.2 Zivak Technologies Business Overview
11.10.3 Zivak Technologies Newborn Metabolic Screening Introduction
11.10.4 Zivak Technologies Revenue in Newborn Metabolic Screening Business (2020-2025)
11.10.5 Zivak Technologies Recent Development
11.11 Covidien Plc
11.11.1 Covidien Plc Company Details
11.11.2 Covidien Plc Business Overview
11.11.3 Covidien Plc Newborn Metabolic Screening Introduction
11.11.4 Covidien Plc Revenue in Newborn Metabolic Screening Business (2020-2025)
11.11.5 Covidien Plc Recent Development
11.12 AB Sciex LLC
11.12.1 AB Sciex LLC Company Details
11.12.2 AB Sciex LLC Business Overview
11.12.3 AB Sciex LLC Newborn Metabolic Screening Introduction
11.12.4 AB Sciex LLC Revenue in Newborn Metabolic Screening Business (2020-2025)
11.12.5 AB Sciex LLC Recent Development
11.13 Waters Corp.
11.13.1 Waters Corp. Company Details
11.13.2 Waters Corp. Business Overview
11.13.3 Waters Corp. Newborn Metabolic Screening Introduction
11.13.4 Waters Corp. Revenue in Newborn Metabolic Screening Business (2020-2025)
11.13.5 Waters Corp. Recent Development
11.14 Masimo Corp.
11.14.1 Masimo Corp. Company Details
11.14.2 Masimo Corp. Business Overview
11.14.3 Masimo Corp. Newborn Metabolic Screening Introduction
11.14.4 Masimo Corp. Revenue in Newborn Metabolic Screening Business (2020-2025)
11.14.5 Masimo Corp. Recent Development
11.15 Natus Medical Inc.
11.15.1 Natus Medical Inc. Company Details
11.15.2 Natus Medical Inc. Business Overview
11.15.3 Natus Medical Inc. Newborn Metabolic Screening Introduction
11.15.4 Natus Medical Inc. Revenue in Newborn Metabolic Screening Business (2020-2025)
11.15.5 Natus Medical Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Newborn Metabolic Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blood Test
 Table 3. Key Players of Urine Test
 Table 4. Global Newborn Metabolic Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Newborn Metabolic Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Newborn Metabolic Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Newborn Metabolic Screening Market Share by Region (2020-2025)
 Table 8. Global Newborn Metabolic Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Newborn Metabolic Screening Market Share by Region (2026-2031)
 Table 10. Newborn Metabolic Screening Market Trends
 Table 11. Newborn Metabolic Screening Market Drivers
 Table 12. Newborn Metabolic Screening Market Challenges
 Table 13. Newborn Metabolic Screening Market Restraints
 Table 14. Global Newborn Metabolic Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Newborn Metabolic Screening Market Share by Players (2020-2025)
 Table 16. Global Top Newborn Metabolic Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Metabolic Screening as of 2024)
 Table 17. Ranking of Global Top Newborn Metabolic Screening Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Newborn Metabolic Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Newborn Metabolic Screening, Headquarters and Area Served
 Table 20. Global Key Players of Newborn Metabolic Screening, Product and Application
 Table 21. Global Key Players of Newborn Metabolic Screening, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Newborn Metabolic Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Newborn Metabolic Screening Revenue Market Share by Type (2020-2025)
 Table 25. Global Newborn Metabolic Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Newborn Metabolic Screening Revenue Market Share by Type (2026-2031)
 Table 27. Global Newborn Metabolic Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Newborn Metabolic Screening Revenue Market Share by Application (2020-2025)
 Table 29. Global Newborn Metabolic Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Newborn Metabolic Screening Revenue Market Share by Application (2026-2031)
 Table 31. North America Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Newborn Metabolic Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Newborn Metabolic Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Newborn Metabolic Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Newborn Metabolic Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Newborn Metabolic Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Newborn Metabolic Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Newborn Metabolic Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Newborn Metabolic Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Newborn Metabolic Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Newborn Metabolic Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Newborn Metabolic Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 46. PerkinElmer Company Details
 Table 47. PerkinElmer Business Overview
 Table 48. PerkinElmer Newborn Metabolic Screening Product
 Table 49. PerkinElmer Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 50. PerkinElmer Recent Development
 Table 51. Bio-Rad Laboratories Company Details
 Table 52. Bio-Rad Laboratories Business Overview
 Table 53. Bio-Rad Laboratories Newborn Metabolic Screening Product
 Table 54. Bio-Rad Laboratories Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 55. Bio-Rad Laboratories Recent Development
 Table 56. Trivitron Healthcare Private Limited Company Details
 Table 57. Trivitron Healthcare Private Limited Business Overview
 Table 58. Trivitron Healthcare Private Limited Newborn Metabolic Screening Product
 Table 59. Trivitron Healthcare Private Limited Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 60. Trivitron Healthcare Private Limited Recent Development
 Table 61. BioMedomics, Inc. Company Details
 Table 62. BioMedomics, Inc. Business Overview
 Table 63. BioMedomics, Inc. Newborn Metabolic Screening Product
 Table 64. BioMedomics, Inc. Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 65. BioMedomics, Inc. Recent Development
 Table 66. Luminex Corporation Company Details
 Table 67. Luminex Corporation Business Overview
 Table 68. Luminex Corporation Newborn Metabolic Screening Product
 Table 69. Luminex Corporation Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 70. Luminex Corporation Recent Development
 Table 71. MP BIOMEDICALS Company Details
 Table 72. MP BIOMEDICALS Business Overview
 Table 73. MP BIOMEDICALS Newborn Metabolic Screening Product
 Table 74. MP BIOMEDICALS Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 75. MP BIOMEDICALS Recent Development
 Table 76. Synergy Medical Systems LLP Company Details
 Table 77. Synergy Medical Systems LLP Business Overview
 Table 78. Synergy Medical Systems LLP Newborn Metabolic Screening Product
 Table 79. Synergy Medical Systems LLP Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 80. Synergy Medical Systems LLP Recent Development
 Table 81. Agilent Technologies, Inc Company Details
 Table 82. Agilent Technologies, Inc Business Overview
 Table 83. Agilent Technologies, Inc Newborn Metabolic Screening Product
 Table 84. Agilent Technologies, Inc Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 85. Agilent Technologies, Inc Recent Development
 Table 86. Thermo Fisher Scientific, Inc Company Details
 Table 87. Thermo Fisher Scientific, Inc Business Overview
 Table 88. Thermo Fisher Scientific, Inc Newborn Metabolic Screening Product
 Table 89. Thermo Fisher Scientific, Inc Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 90. Thermo Fisher Scientific, Inc Recent Development
 Table 91. Zivak Technologies Company Details
 Table 92. Zivak Technologies Business Overview
 Table 93. Zivak Technologies Newborn Metabolic Screening Product
 Table 94. Zivak Technologies Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 95. Zivak Technologies Recent Development
 Table 96. Covidien Plc Company Details
 Table 97. Covidien Plc Business Overview
 Table 98. Covidien Plc Newborn Metabolic Screening Product
 Table 99. Covidien Plc Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 100. Covidien Plc Recent Development
 Table 101. AB Sciex LLC Company Details
 Table 102. AB Sciex LLC Business Overview
 Table 103. AB Sciex LLC Newborn Metabolic Screening Product
 Table 104. AB Sciex LLC Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 105. AB Sciex LLC Recent Development
 Table 106. Waters Corp. Company Details
 Table 107. Waters Corp. Business Overview
 Table 108. Waters Corp. Newborn Metabolic Screening Product
 Table 109. Waters Corp. Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 110. Waters Corp. Recent Development
 Table 111. Masimo Corp. Company Details
 Table 112. Masimo Corp. Business Overview
 Table 113. Masimo Corp. Newborn Metabolic Screening Product
 Table 114. Masimo Corp. Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 115. Masimo Corp. Recent Development
 Table 116. Natus Medical Inc. Company Details
 Table 117. Natus Medical Inc. Business Overview
 Table 118. Natus Medical Inc. Newborn Metabolic Screening Product
 Table 119. Natus Medical Inc. Revenue in Newborn Metabolic Screening Business (2020-2025) & (US$ Million)
 Table 120. Natus Medical Inc. Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Newborn Metabolic Screening Picture
 Figure 2. Global Newborn Metabolic Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Newborn Metabolic Screening Market Share by Type: 2024 VS 2031
 Figure 4. Blood Test Features
 Figure 5. Urine Test Features
 Figure 6. Global Newborn Metabolic Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Newborn Metabolic Screening Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Specialty Clinic Case Studies
 Figure 10. Others Case Studies
 Figure 11. Newborn Metabolic Screening Report Years Considered
 Figure 12. Global Newborn Metabolic Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Newborn Metabolic Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Newborn Metabolic Screening Market Share by Region: 2024 VS 2031
 Figure 15. Global Newborn Metabolic Screening Market Share by Players in 2024
 Figure 16. Global Top Newborn Metabolic Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Metabolic Screening as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Newborn Metabolic Screening Revenue in 2024
 Figure 18. North America Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Newborn Metabolic Screening Market Share by Country (2020-2031)
 Figure 20. United States Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Newborn Metabolic Screening Market Share by Country (2020-2031)
 Figure 24. Germany Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Newborn Metabolic Screening Market Share by Region (2020-2031)
 Figure 32. China Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Newborn Metabolic Screening Market Share by Country (2020-2031)
 Figure 40. Mexico Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Newborn Metabolic Screening Market Share by Country (2020-2031)
 Figure 44. Turkey Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Newborn Metabolic Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. PerkinElmer Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 48. Bio-Rad Laboratories Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 49. Trivitron Healthcare Private Limited Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 50. BioMedomics, Inc. Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 51. Luminex Corporation Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 52. MP BIOMEDICALS Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 53. Synergy Medical Systems LLP Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 54. Agilent Technologies, Inc Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 55. Thermo Fisher Scientific, Inc Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 56. Zivak Technologies Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 57. Covidien Plc Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 58. AB Sciex LLC Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 59. Waters Corp. Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 60. Masimo Corp. Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 61. Natus Medical Inc. Revenue Growth Rate in Newborn Metabolic Screening Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD